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Abstract
Background: Approximately 11% of the German population are convinced that certain moon phases and moon
signs may impact their health and the onset and clinical course of diseases. Before elective surgery, a considerable
number of patients look to optimize the timing of the procedure based on the lunar cycle. Especially patients
awaiting living donor kidney transplantation (LDKT) commonly look for an adjustment of the date of transplantation
according to the moon calendar. This study therefore investigated the perioperative and long-term outcome of LDKT
dependent on moon phases and zodiac signs.
Methods: Patient data were prospectively collected in a continuously updated kidney transplant database. Two hundred
and seventy-eight consecutive patients who underwent LDKT between 1994 and December 2009 were selected for the
study and retrospectively assigned to the four moon phases (new-moon, waxing-moon, full-moon, and waning-moon) and
the corresponding zodiac sign (moon sign Libra), based on the date of transplantation. Preexisting comorbidities,
perioperative mortality, surgical outcome, and long-term survival data were analyzed.
Results: Of all LDKT procedures, 11.9, 39.9, 11.5, and 36.5% were performed during the new, waxing, full, and waning
moon, respectively, and 6.2% during the moon sign Libra, which is believed to interfere with renal surgery. Survival
rates at 1, 5, and 10 years after transplantation were 98.9, 92, and 88.7% (patient survival) and 97.4, 91.6, and 80.6%
(graft survival) without any differences between all groups of lunar phases and moon signs. Overall perioperative
complications and early graft loss occurred in 21.2 and 1.4%, without statistical difference (p > 0.05) between groups.
Conclusion: Moon phases and the moon sign Libra had no impact on early and long-term outcome measures
following LDKT in our study. Thus, concerns of patients awaiting LDKT regarding the ideal time of surgery can be
allayed, and surgery may be scheduled independently of the lunar phases.
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Background
In comparison to deceased donor transplantation, living
donor kidney transplantation (LDKT) provides better
patient and allograft survival. Reasons for this are
shorter cold ischemic times, reduced time on the waiting
list, and the opportunity for patient conditioning as well
as to electively schedule surgery [1, 2]. Moreover, the de-
cision to donate and to accept an organ can improve the
well-being of both donor and recipient [3–6]. Neverthe-
less, the LDKT procedure itself can cause considerable
emotional stress for the donor and the recipient. Since
the German transplantation law does not permit altruis-
tic organ donation, both donor and recipient frequently
have a strong emotional connection (friends or relatives).
Therefore, a positive outcome of the LDKT is generally
expected and complications are considered unaccept-
able. However, between 6 and 25% of the complications
following LDKT may be due to anatomical conditions
(in particular vascular anatomy), AB0 incompatibility,
and the recipient’s nutritional status [7]. As a conse-
quence, it is not uncommon that donors and recipients
wish to reduce the risk of an adverse outcome by select-
ing the best date for the transplantation procedure [4–6,
8–11]. In particular, patients and their relatives some-
times set the date by following superstition-based pre-
dictions. This includes the popular superstition that
moon phases (new-, waxing-, full and waning moon)
and moon signs (zodiac signs of the moon, which are be-
lieved to be associated with a certain part of the human
body) might impact outcome after surgery. According to
medical astrology, surgical interventions performed dur-
ing full moon and moon signs of the corresponding sur-
gical region might have a less favorable outcome (Fig. 1,
[12]). So far, the timing of living donor kidney trans-
plantation according to the lunar cycle and moon signs
has not been investigated. The present work is the first
to provide a structured analysis of the clinical impact of
timing of an LDKT procedure according to moon phases
and the moon sign Libra. The Results of this study
might help surgeons to relieve patients’ concerns about
the wrong timing of surgery.
Methods
Patients
Between 1994 and 2009, a total of 3722 kidney trans-
plantations were performed at our transplant center.
Among those, 278 consecutive pairs of adult living
kidney donors and recipients with prospectively regis-
tered perioperative data, including the donor and recipi-
ent profiles, were evaluated without any exclusions.
Among donor surgeries, not more than three complica-
tions, requiring surgical (n = 1) or radiologic (n = 2)
Fig. 1 Anatomical-astrological human (drawing by © Alla Mikhailova). According to medical astrology, each organ (or organ system) is associated
with a certain moon sign. Note, that the kidneys are assigned to the sign of Libra
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intervention without relation to moon phases were iden-
tified. As a consequence, no reliable conclusion could be
drawn by the analysis of the live kidney donors in our
cohort. Therefore the donors were not included in
further analyses. The recipients’ age varied between 17
and 73 years with exception of three paediatric patients
who were 7, 9, and 14 years old at the time of
transplantation.
Transplantation legislation
All transplantations were performed in accordance with
the legislation of Eurotransplant and Germany. The
medical eligibility of donors and recipients was evaluated
by primary care physicians and nephrologists. Patients’
registration flowcharts were reviewed by an interdiscip-
linary review board of our institution and by an
independent psychologic review board before transplant-
ation. The study was approved by the local committee of
ethics (grant no. 17–151).
Surgical technique and data assessment
Surgical procedures were standardized as previously
described [13, 14]. In the case of chronic graft failure,
the graft was left in situ unless graft-related complica-
tions occurred. At our center, the prospective record-
ing of a recipient’s data starts at the time of
Eurotransplant waiting list registration. Data are up-
dated every 6 months. Additional information about
the clinical post-transplant course not included in the
database was obtained in a 3-step process: informa-
tion was extracted from the institution’s electronic
patient files, checked, and then double checked by
independent coworkers. All patient- and clinical data
were recorded prospectively; moon phases and moon
signs were assigned retrospectively to the date of KT.
The following study provides consistent information
over a minimum of 3-years of follow-up post trans-
plantation, although all patients were registered for
longer than 5 years (i.e. in the context of their first
transplantation). Analyses were carried out in
complete agreement with GCP guidelines for retro-
spective analyses [15] and, as far as applicable,
according to the suggestions of the ISPOR Task Force
on Retrospective Databases for the critical assessment
of retrospective analyses [16].
Timing of surgery, moon phases and zodiac signs
The majority of the transplant procedures had been
planned irrespective of the moon cycle and moon
signs. All surgeries were performed electively without
exception. Therefore, all dates of LDKT were retro-
spectively assigned to the corresponding dates of the
four lunar phases (Fig. 2). Lunar phases were defined
as follows: the period of the new moon was consid-
ered to be ±1 day around the precise day of the new
moon, so the entire new moon phase occupied 3 days.
The full moon phase was defined similarly. The time
interval between the new moon phase and the full
moon phase was defined as the waxing moon phase
and the time interval between the full moon phase
and the new moon phase as the waning moon phase.
Since a lunar month (synodic month) lasts about
29.53 days, the phases of waxing moon and of waning
moon last approximately 12 days and therefore 4-
times longer than the phases of full moon and new
moon (3 days). Moon signs were defined as the signs
of the Zodiac in which the moon was at the time of
the operation. Lunar phases and moon signs for each
date of transplantation were acquired from StarDate
Online (online service of the University of Texas
McDonald Observatory) [17]. According to medical
astrology, the moon sign Libra is considered critical
for renal and urogenital surgery (Fig. 1). Therefore,
we additionally divided the patient cohort into two
groups: those who underwent LDKT during the moon
sign Libra, and those who did not.
Fig. 2 Moon phases as seen looking southwards from the northern hemisphere (upper part of the diagram not to scale, as the Earth-Moon distance is
much bigger than shown here; © Orion 8/Wikimedia Commons/CC-BY-SA-3.0)
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Immunosuppressive regimen
Graft recipients were treated with cyclosporine A
(3 mg/kg) and prednisolone (250 mg). In addition,
immunosuppression included azathioprine (2 mg/kg)
or mycophenolate mofetil (MMF, 3 × 1,000 mg/d).
Anti-thymocyte globuline (ATG-Fresenius®, 4 mg/kg)
was administered as an induction regimen. Patients
with re-transplantations were considered to be at a
higher immunological risk and received tacrolimus
(initial dose: 0.01 mg/kg) and 20 mg basiliximab plus
ATG (1 mg/kg) as an induction regimen unless the
preformed antibody ratio (PRA) was below 20%,
according to the centers immunosuppressive protocol.
Cytomegalovirus (CMV) prophylaxis was administered
in all patients unless both the donor and the recipient
were known to have a CMV-negative serologic status.
Outcome measures definition
The following data were collected for each patient with
regard to the date of transplantation: age, gender, total
duration of dialysis, duration of the surgical procedure,
postoperative morbidity and mortality, graft function
(serum creatinine levels), rejection episodes, length of
hospital stay, long-term complications, graft and patient
survival rates, and causes of graft failure and/or patient
death. Acute rejections were biopsy-proven and classi-
fied according to the BANFF ‘07 classification [18]. For
statistical analysis, only rejections grade 3 and 4 (IA, B
and IIA, B) were taken into account. Delayed graft func-
tion was defined as need for dialysis, or the absence of a
spontaneous drop in serum creatinine within 7 days of
transplantation after ruling out accelerated rejection,
vascular complications, or urinary tract obstruction [19].
Postoperative morbidity was defined as any postopera-
tive surgical or general complication following trans-
plantation. Postoperative surgical complications such as
vascular complications, ureteral complications, events of
graft rupture and dislocation, development of lympho-
celes, peritonitis, postoperative hemorrhage, events of
wound dehiscence, as well as superficial and deep
wound infection were recorded as described previously
[20, 21]. In addition, the following types of general com-
plications were registered: cardiac events, respiratory
events, urinary tract infection, gastrointestinal bleeding
and multi-organ failure.
Statistical analysis
Continuous variables are presented as median (range),
and categorical variables as total number (percentage).
The Kruskal-Wallis- or the Mann–Whitney-U test were
used for all comparisons among continuous variables.
Categorical variables were compared by Pearson’s Chi-
square statistics or Fisher’s exact test for small sample
sizes. A p-value of 0.05 or less in a two-tailed test was
considered statistically significant. Survival was analyzed
using Kaplan-Meier estimates, and survival rates were
analyzed using the log-rank test. All statistical analyses
were performed using a SPSS Package (PASW version
17.0, SPSS Inc. U.S.A).
Results
Moon phases and moon signs
Thirty-three LDKT (11.9%) were performed during the
new moon, 111 (39.9%) during the waning moon, 32
(11.5%) during the full moon, and 102 (36.7%) during
the waxing moon. Therefore, all transplant procedures
were distributed homogeneously among the main moon
phases: new moon + waxing moon with 51.8% and full
moon + waning moon with 48.2%. Seventeen of 273
transplantations (6.2%) were performed during the moon
sign Libra.
Demographics and medical history
Demographics and preoperative clinical data of all
patients are shown in Table 1. Of the 278 patients, 192
(69.1%) were male and 86 (30.9%) were female. The
median age and the median body mass index of all
recipients were 42 years and 23.8 kg/m2, respectively.
The median total duration of dialysis prior to LDKT was
1.96 years, and 30 patients (10.8%) underwent peritoneal
dialysis before. Main causes of terminal kidney failure
prior to transplantation were chronic glomerulonephritis
(n = 88, 31.7%), IgA nephritis (n = 24, 8.6%), polycystic
kidney disease (n = 19, 6.8%), and diabetic nephropathy
(n = 13, 4.7%). Thirty-three patients (11.9%) had more
than one kidney transplantation prior to LDKT. All
patients were clinically followed up for a median
duration of 8.2 years after LDKT. No differences were
seen between all groups of lunar phases and the group
of the moon sign libra, with respect to patient’s
demographics, underlying kidney disease, medical- and
transplant history (Table 1).
Postoperative course
Operative data and the clinical course of patients are
shown in Table 2. No significant differences between all
groups were found regarding duration of the procedure,
postoperative length of stay, postoperative morbidity,
rejection episodes, graft loss and 90-day-mortality. Over-
all, 59 patients (21.2%) developed postoperative surgical
complications, and 26 patients (9.4%) demonstrated
delayed graft function without significant differences
across the study groups; early graft loss (<30 days after
transplantation) occurred in four patients (1.4%). With
regard to the date of LDKT, patient and graft survival
rates at 1, 5, and 10 years were 98.9, 92, and 88.7%, and
97.4, 91.6, and 80.6%, respectively (Fig. 3). The timing of
surgery with respect to the moon phases and the moon
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sign Libra showed no significant impact on long-term
patient and graft survival (Figs. 4 and 5). Taken together,
we cannot demonstrate any influence of moon phases
and the moon sign Libra on the peri- and postoperative
course of LDKT patients. In contrast to graft recipients,
live donors revealed postoperative complications which
required surgical or radiological revision in only 1.1%
without relation to moon phases or Libra sign.
Discussion
The present single center cohort study could reveal that
timing of transplant surgery according to moon phases
or the moon sign Libra generally had no measurable
impact on short- and long-term outcome after living
donor kidney transplantation.
Even in modern ‘informed’ societies, superstition still
plays a significant role. Only a small proportion of
people approach life in an entirely rational way [22].
Since superstition is in general often tied to unpredict-
able events beyond personal control, people may rely on
astrology to predict the future. Even today, the concept
of lunar phases influencing different aspects of daily life
is very popular. The moon phase hypothesis, almost
completely abandoned by the medical field since 1700
[23], had a renaissance in the second half of the 20th
century after a report by Andrews in 1960 who
observed an increased incidence of bleeding complica-
tions after tonsillectomies carried out during the full
moon [8]. Studies in terms of an influence of the
moon phases on human life thereafter were inconclu-
sive [9, 10, 24–34], or failed to confirm it [35–38].
Nevertheless, several studies demonstrated significant
differences in social life, for example in alcohol
consumption, nutritional intake, birth rates, and the
frequency of incidents such as crime, self-poisoning,
suicide and traffic accidents, during the four moon
phases [25, 31–34]. Moreover, general practice con-
sultation rates and hospital admissions for anxiety,
depression, acute diarrhea, gastrointestinal bleeding,
atrial fibrillation, myocardial infarction and cardiac
arrest have been found to vary throughout the lunar
cycle [9, 10, 24, 26–30]. These reconfirmed a pre-
sumed dependence of social life and humans physical
condition on a superordinate authority such as moon
phases and moon signs. Accidents, violence, births
rates and acute illnesses, however, can hardly be in-
fluenced or timely scheduled by humans. In the same
Fig. 3 Patient- and graft survival after living donor kidney transplantation
(LDKT). Patient- and graft-survival rates at 1, 5, and 10 years after
transplantation were 98.9, 92, and 88.7% and 97.4, 91.6, and
80.6%, respectively
Fig. 4 a Patient- and (b) graft survival after living donor kidney
transplantation (LDKT) in recipients, grouped according to the four
main moon phases: new moon (NM); waxing moon (WaxM); full moon
(FM) and waning moon (WanM). The full moon phase, which, according
to medical astrology, should be avoided for operations, did not show a
worse course than other moon phases
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sense, postoperative complications following trans-
plantation in general occur by hazard. Therefore these
results remain observantly. With regard to elective
treatment, however, the question arises of how the
physical condition of the doctor on one hand, and
how the patients healing course on the other hand
might be influenced by different phases of the moon.
Furthermore, a specific timing of the treatment might
improve the patient’s outcome. About 10.5% of the
German population believes that particular moon
phases influence disease onset, clinical course, and
recovery. This number is even higher in the South of
Germany where our transplant center is located.
Here, up to 17.9% believe in the moon phase hypoth-
esis [11]. In this context no clear scientific opinion
on the influence of lunar phases on surgical outcome
exists, and only few data is available to physicians
and surgeons with which to relieve the patients’
concerns about wrong timing of surgery. Some stud-
ies have analyzed surgical outcome as a function of
moon phases. Most of these studies could demon-
strate no relationship between the lunar cycle and
postoperative outcome after elective ambulantory
surgery, surgery performed under general anesthesia,
or more specific after breast cancer-, lung cancer-,
bladder cancer- or ENT surgery [11, 36–39].
The reason for the present study was due to an
increasing patient demand for moon-phase-adjusted
transplant appointments in our own department.
Especially in transplantation medicine, the mental and
psychological stress of all participants, especially
donors and recipients is very high. Factors, such as
the live organ of a closely related party, the threat of
a life-threatening illness, the vague hope of cure but
also the knowledge about the limited life-span of the
new organ,put the patients under enormous pressure.
All thinkable efforts are in general made in order to
increase the likelihood of a perfect long term organ
survival. Not surprisingly, our patient managers have
to consult lunar calendars during the planning of
LDKT appointments with increasing frequency.
However, it is not always possible to accommodate
the patients’ wish dates.
The present study has some limitations. First, it is a
retrospective analysis of a single transplant center and
the number of patients is limited. In addition, due to
the retrospective design of our study, no randomization
of the patients was realized.. However, a randomization
of the patients would systematically ignore the patients
preferences. Realization of such a randomized trial
would therefore be challenging. As a consequence, we
do not know in how many cases the transplant was
scheduled according to the lunar phases on the explicit
request of the patient. It would be interesting to know
whether a strong desire of the patient and a corre-
sponding fulfillment has any influence on the short-
and long-term success of the surgery. It cannot be
excluded that the patient’s fear of wrong timing of the
transplantation might have a significant negative
influence on postoperative recovery and outcome,
irrespective of any influence of the moon.
However, the results of the present study revealed that
the moon phases and the position of the moon in the
moon sign Libra generally had no measurable impact on
short- and long-term outcome after LDKT. These results
are suitable to ease recipients, donors and relatives, if a
transplantation procedure according to the moon cycle
is not possible.
Conclusion
Our data indicate that there is no connection between
moon phases, moon signs and results after living donor
Fig. 5 a Patient- and (b) graft survival after living donor kidney
transplantation (LDKT) in recipients, grouped according to the moon
sign Libra, which, according to medical astrology, is believed to interfere
with surgical procedures of the kidneys and the urinary tract
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kidney transplantation (LDTK). On the other hand, phy-
sicians and surgeons should consider their patients’ pref-
erences, wishes, and beliefs first. Therefore, patients who
strongly confide in the impact of the moon phases on
the outcome of surgery should be taken seriously and
the correct timing of transplantation should be facili-
tated as long as it does not interfere with evidence-based
treatment and center-specific regimens.
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